TY - JOUR
T1 - Predicting the multi-domain progression of Parkinson's disease
T2 - A Bayesian multivariate generalized linear mixed-effect model
AU - Wang, Ming
AU - Li, Zheng
AU - Lee, Eun Young
AU - Lewis, Mechelle M.
AU - Zhang, Lijun
AU - Sterling, Nicholas W.
AU - Wagner, Daymond
AU - Eslinger, Paul
AU - Du, Guangwei
AU - Huang, Xuemei
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/9/25
Y1 - 2017/9/25
N2 - Background: It is challenging for current statistical models to predict clinical progression of Parkinson's disease (PD) because of the involvement of multi-domains and longitudinal data. Methods: Past univariate longitudinal or multivariate analyses from cross-sectional trials have limited power to predict individual outcomes or a single moment. The multivariate generalized linear mixed-effect model (GLMM) under the Bayesian framework was proposed to study multi-domain longitudinal outcomes obtained at baseline, 18-, and 36-month. The outcomes included motor, non-motor, and postural instability scores from the MDS-UPDRS, and demographic and standardized clinical data were utilized as covariates. The dynamic prediction was performed for both internal and external subjects using the samples from the posterior distributions of the parameter estimates and random effects, and also the predictive accuracy was evaluated based on the root of mean square error (RMSE), absolute bias (AB) and the area under the receiver operating characteristic (ROC) curve. Results: First, our prediction model identified clinical data that were differentially associated with motor, non-motor, and postural stability scores. Second, the predictive accuracy of our model for the training data was assessed, and improved prediction was gained in particularly for non-motor (RMSE and AB: 2.89 and 2.20) compared to univariate analysis (RMSE and AB: 3.04 and 2.35). Third, the individual-level predictions of longitudinal trajectories for the testing data were performed, with ~80% observed values falling within the 95% credible intervals. Conclusions: Multivariate general mixed models hold promise to predict clinical progression of individual outcomes in PD. Trial registration: The data was obtained from Dr. Xuemei Huang's NIH grant R01 NS060722, part of NINDS PD Biomarker Program (PDBP). All data was entered within 24 h of collection to the Data Management Repository (DMR), which is publically available (https://pdbp.ninds.nih.gov/data-management).
AB - Background: It is challenging for current statistical models to predict clinical progression of Parkinson's disease (PD) because of the involvement of multi-domains and longitudinal data. Methods: Past univariate longitudinal or multivariate analyses from cross-sectional trials have limited power to predict individual outcomes or a single moment. The multivariate generalized linear mixed-effect model (GLMM) under the Bayesian framework was proposed to study multi-domain longitudinal outcomes obtained at baseline, 18-, and 36-month. The outcomes included motor, non-motor, and postural instability scores from the MDS-UPDRS, and demographic and standardized clinical data were utilized as covariates. The dynamic prediction was performed for both internal and external subjects using the samples from the posterior distributions of the parameter estimates and random effects, and also the predictive accuracy was evaluated based on the root of mean square error (RMSE), absolute bias (AB) and the area under the receiver operating characteristic (ROC) curve. Results: First, our prediction model identified clinical data that were differentially associated with motor, non-motor, and postural stability scores. Second, the predictive accuracy of our model for the training data was assessed, and improved prediction was gained in particularly for non-motor (RMSE and AB: 2.89 and 2.20) compared to univariate analysis (RMSE and AB: 3.04 and 2.35). Third, the individual-level predictions of longitudinal trajectories for the testing data were performed, with ~80% observed values falling within the 95% credible intervals. Conclusions: Multivariate general mixed models hold promise to predict clinical progression of individual outcomes in PD. Trial registration: The data was obtained from Dr. Xuemei Huang's NIH grant R01 NS060722, part of NINDS PD Biomarker Program (PDBP). All data was entered within 24 h of collection to the Data Management Repository (DMR), which is publically available (https://pdbp.ninds.nih.gov/data-management).
UR - http://www.scopus.com/inward/record.url?scp=85029893487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029893487&partnerID=8YFLogxK
U2 - 10.1186/s12874-017-0415-4
DO - 10.1186/s12874-017-0415-4
M3 - Article
C2 - 28946857
AN - SCOPUS:85029893487
SN - 1471-2288
VL - 17
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
IS - 1
M1 - 147
ER -